Thomas Steyer’s Terns Pharmaceuticals TERN Stock Holding History

Thomas Steyer’s Portfolio TERN Stock Details TERN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-7,000	Closed	-$369K	–	177
2026 Q1	$369K	Sell	7,000 -635,000	-99%	-$26.1M	﹤0.01%	111
2025 Q4	$25.9M	Buy	+642,000	New	+$14.8M	0.11%	67

Other funds holding TERN

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Thomas Steyer's TERN Position: Q2 2026 in Review

Thomas Steyer sold out of Terns Pharmaceuticals (TERN) in Q2 2026, closing a stake of 7,000 shares — an estimated $369K sold.

Thomas Steyer first reported a position in TERN in Q4 2025 and held it in 2 quarters. The position peaked at $25.9M in Q4 2025. 1 fund tracked by Wall St. Rank holds TERN as of Q2 2026.

Thomas Steyer reported no remaining Terns Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
Thomas Steyer sold 7,000 Terns Pharmaceuticals shares in Q2 2026, an estimated $369K.
Thomas Steyer first reported a position in Terns Pharmaceuticals in Q4 2025 and held it in 2 quarters.
Thomas Steyer's Terns Pharmaceuticals position peaked at $25.9M in Q4 2025.
1 fund tracked by Wall St. Rank held Terns Pharmaceuticals as of Q2 2026.

Based on Farallon Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.